Ironwoodcap: Torigen Pharmaceuticals Closes $13M Series A1 Funding Round

Torigen Pharmaceutical, a Farmington, CT-based commercial-stage animal health biologics company, raised $13M Series A1 funding. The round was led by Werth Family Investment Associates, and Connecticut Innovations, with participation from Emerald Development Managers, Gaingels, Kema Fund, University of Notre Dame, SoGal Ventures, UCONN Innovation Fund, Ironwood Capital and Advantage Capital. The company intends to use [...]The post Torigen Pharmaceuticals Closes $13M Series A1 Funding Round appeared first on FinSMEs.